ALDH1 mediates resistance to chemotherapy via direct involvement of drug metabolism and ROS regulation, and high ALDH activity was reported as a prognostic marker and a therapeutic target in many cancers including ovarian cancer [8,22]. Here, ALDH1A1 is linked to cancer.